STEMEX Trademark

Trademark Overview

On Monday, March 27, 2000, a trademark application was filed for STEMEX with the United States Patent and Trademark Office. The USPTO has given the STEMEX trademark a serial number of 76010247. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 24, 2023. This trademark is owned by GAMIDA-CELL LTD.. The STEMEX trademark is filed in the Pharmaceutical Products category with the following description:

Expanded cord blood stem cells for clinical treatment of cancer and genetic diseases
stemex

General Information

Serial Number76010247
Word MarkSTEMEX
Filing DateMonday, March 27, 2000
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 24, 2023
Registration Number2716098
Registration DateTuesday, May 13, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 30, 2001

Trademark Statements

Goods and ServicesExpanded cord blood stem cells for clinical treatment of cancer and genetic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 24, 2023
Primary Code005
First Use Anywhere DateSunday, December 31, 2000
First Use In Commerce DateSunday, December 31, 2000

Trademark Owner History

Party NameGAMIDA-CELL LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJerusalem 95484
IL
Party NameGAMIDA-CELL LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJerusalem 95484
IL
Party NameGAMIDA-CELL LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJerusalem 95464
IL

Trademark Events

Event DateEvent Description
Friday, November 24, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Friday, May 13, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, August 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 30, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 30, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 1, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, June 1, 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, June 1, 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, June 1, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 6, 2013TEAS SECTION 8 & 9 RECEIVED
Wednesday, May 13, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, May 12, 2009ASSIGNED TO PARALEGAL
Thursday, May 7, 2009TEAS SECTION 8 & 15 RECEIVED
Wednesday, December 12, 2007CASE FILE IN TICRS
Tuesday, October 10, 2006REVIEW OF CORRESPONDENCE COMPLETE
Monday, August 29, 2005PAPER RECEIVED
Tuesday, May 13, 2003REGISTERED-PRINCIPAL REGISTER
Tuesday, March 18, 2003ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 13, 2003ASSIGNED TO EXAMINER
Thursday, March 6, 2003STATEMENT OF USE PROCESSING COMPLETE
Monday, December 16, 2002USE AMENDMENT FILED
Monday, December 16, 2002PAPER RECEIVED
Thursday, March 28, 2002SOU EXTENSION 1 GRANTED
Friday, March 8, 2002SOU EXTENSION 1 FILED
Tuesday, January 22, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 30, 2001PUBLISHED FOR OPPOSITION
Thursday, June 21, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 5, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 12, 2001FINAL REFUSAL MAILED
Wednesday, December 13, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 15, 2000NON-FINAL ACTION MAILED
Monday, September 11, 2000ASSIGNED TO EXAMINER

Related Keywords

stemex treatment cancer genetic diseases clinical cells cord blood stem expanded